Patent 6905684 was granted and assigned to Mochida Pharmaceutical on June, 2005 by the United States Patent and Trademark Office.
Preventives and remedies for diffuse lung diseases whereby apoptosis can be inhibited and thus favorable preventive/therapeutic effects can be established.